Lv1
80 积分 2024-07-01 加入
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
14天前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
20天前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
20天前
已完结
Smoking and lung cancer: recent evidence and a discussion of some questions*
27天前
已完结
Non-invasive assessment of MASH resolution
28天前
已完结
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH
28天前
已完结
The changing landscape of atherosclerosis
1个月前
已完结
Atherosclerosis — An Inflammatory Disease
1个月前
已完结
Mitochondrial complex I activity in microglia sustains neuroinflammation
1个月前
已完结
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
1个月前
已完结
皖公网安备34019202002308
